Vascular Biogenics Ltd. (VBLT) |
|
1.23 -0.05 (-3.91%)
|
07-01 16:00 |
|
Open: |
1.27 |
Pre. Close: |
1.28 |
|
High:
|
1.27 |
Low:
|
1.22 |
|
Volume:
|
142,040 |
Market Cap:
|
59M |
|
|
|
|
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes genetically targeted therapy to destroy newly formed or angiogenic blood vessels. Its lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; and in Phase III clinical trials for recurrent platinum-resistant ovarian cancer, as well as for Phase II clinical trials for iodine-resistant differentiated thyroid cancer. The company is also developing VB-111, which is in Phase I clinical trials for the treatment of patients with various types of advanced metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma, and lung cancer. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.272 - 1.279 |
1.279 - 1.285 |
|
Low:
|
1.201 - 1.211 |
1.211 - 1.218 |
|
Close:
|
1.217 - 1.231 |
1.231 - 1.242 |
|
Technical analysis |
as of: 2020-07-01 4:37:59 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.66 One year: 1.89 |
| Support: |
Support1: 1.09 Support2: 0.91 |
| Resistance: |
Resistance1: 1.42 Resistance2: 1.62 |
| Pivot: |
1.27 |
| Moving Average: |
MA(5): 1.27 MA(20): 1.28
MA(100): 1.29 MA(250): 1.28 |
| MACD: |
MACD(12,26): Signal(9): |
| Stochastic oscillator: |
%K(14,3): 32.70 %D(3): 33.88 |
| RSI: |
RSI(14): 46.03 |
| 52-week: |
High: 1.64 Low: 0.90 Change(%): -5.4 |
| Average Vol(K): |
3-Month: 61143 10-Days: 46680 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.VBLT has closed above bottom band by 28.2%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to VBLT's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 30 Jun 2020
Vascular Biogenics Ltd. (VBLT) Might Be Poised For A Short Term Move - Invest Million
Thu, 25 Jun 2020
Growth Investors: Industry Analysts Just Upgraded Their Vascular Biogenics Ltd. (NASDAQ:VBLT) Revenue Forecasts By 24% - Yahoo Finance
Tue, 23 Jun 2020
Vascular Biogenics Ltd. (NASDAQ:VBLT) 28.57% Above its 52-week Low, How Long Will it Keep Rising? - Marketing Sentinel
Thu, 18 Jun 2020
Vascular Biogenics Ltd. (VBLT): What is good about stock? - Marketing Sentinel
Thu, 18 Jun 2020
How Does Vascular Biogenics Ltd (VBLT) Stock Rank in the Healthcare Sector? - InvestorsObserver
Wed, 17 Jun 2020
Market's View on Vascular Biogenics Ltd (VBLT) Stock's Price & Volume Trends - InvestorsObserver
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
48 |
| Shares Float (M) |
20 |
|
% Held by Insiders
|
26.73 |
|
% Held by Institutions
|
22.85 |
|
Shares Short (K)
|
252 |
|
Shares Short P. Month (K)
|
76 |
Stock Financials |
|
EPS
|
-0.574 |
|
EPS Est This Year
|
-0.740 |
|
EPS Est Next Year
|
-0.780 |
|
Book Value (p.s.)
|
0.860 |
|
Profit Margin
|
|
|
Operating Margin
|
-2995.35 |
|
Return on Assets (ttm)
|
-25.7 |
|
Return on Equity (ttm)
|
-50.9 |
|
Qtrly Rev. Growth
|
67.1 |
|
Gross Profit (p.s.)
|
0.008 |
|
Sales Per Share
|
0.015 |
|
EBITDA (p.s.)
|
-0.422 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-16 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-2.14 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.43 |
|
Price to Sales
|
83.10 |
|
Price to Cash Flow
|
-3.78 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
